Slovakia has been Europe’s fastest growing economy over the last ten years and the government has identified areas within life sciences as strategic centers for investment in the country. Slovakia has a lot to offer biopharma investors according to Robert Simoncic, head of the Slovak investment and trade development agency (SARIO).
What are the key functions and aims of SARIO?
We work with foreign and domestic firms concerning both inward and outward investment, and carry out a variety of activities to drive economic growth and improvements in the quality and sophistication of economic activity in Slovakia.
